|
Q2 FY2018
As of Oct 31, 2017
|
Q1 FY2018
As of Jul 31, 2017
|
Q4 FY2017
As of Apr 30, 2017
|
Q3 FY2017
As of Jan 31, 2017
|
Q2 FY2017
As of Oct 31, 2016
|
Q1 FY2017
As of Jul 31, 2016
|
Q4 FY2016
As of Apr 30, 2016
|
Q3 FY2016
As of Jan 31, 2016
|
Q2 FY2016
As of Oct 31, 2015
|
Q1 FY2016
As of Jul 31, 2015
|
Q4 FY2015
As of Apr 30, 2015
|
Q3 FY2015
As of Jan 31, 2015
|
Q2 FY2015
As of Oct 31, 2014
|
Q1 FY2015
As of Jul 31, 2014
|
Q4 FY2014
As of Apr 30, 2014
|
Q3 FY2014
As of Jan 31, 2014
|
Q2 FY2014
As of Oct 31, 2013
|
Q1 FY2014
As of Jul 31, 2013
|
Q4 FY2013
As of Apr 30, 2013
|
Q3 FY2013
As of Jan 31, 2013
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Short-term investments | ||||||||||||||||||||
| Accounts receivable, net of allowance for doubtful accounts of $1,058 and $1,260 as of October 31, 2017 and April 30, 2017, respectively | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, equipment and capitalized internal-use software development costs, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Acquired intangible assets, net | ||||||||||||||||||||
| Other non-current assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and stockholders' equity | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses and other current liabilities | ||||||||||||||||||||
| Revolving line of credit | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term liabilities: | ||||||||||||||||||||
| Revolving line of credit | ||||||||||||||||||||
| Deferred revenue less current portion | ||||||||||||||||||||
| Deferred tax liability, long-term | ||||||||||||||||||||
| Other liabilities, long-term | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Common stock – $0.0001 par value; 150,000,000 shares authorized, 86,252,850 shares issued and 86,052,850 shares outstanding as of October 31, 2017; 150,000,000 shares authorized, 84,487,847 shares issued and 84,287,847 shares outstanding at April 30, 2017 | ||||||||||||||||||||
| Treasury stock, at cost – 200,000 shares as of October 31, 2017 and April 30, 2017 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...
